3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Burkitt Lymphoma
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoma, Large B-Cell, Diffuse
4
Prostatic Neoplasms
3
Leukemia, Biphenotypic, Acute
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasms
2
Lymphoma, Follicular
2
Down Syndrome
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Metastatic Castration-resistant Prostate Cancer
1
Lymphoma, Non-Hodgkin
1
Lymphoma, B-Cell
1
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1
Hodgkin Disease
1
Bulbo-Spinal Atrophy, X-Linked
1
Interventions
Cyclophosphamide
9
fludarabine
7
Dexamethasone
7
pomalidomide
6
Rituximab
6
pembrolizumab
5
selinexor
4
obinutuzumab
4
glofitamab
4
Lenalidomide
4
daratumumab
3
belantamab mafodotin
3
Temozolomide
3
Gemcitabine
3
Etoposide
3
Bortezomib
3
zanubrutinib
2
venetoclax
2
tocilizumab
2
fludarabine phosphate
2
enzalutamide
2
cemiplimab
2
carfilzomib
2
abemaciclib
2
PF06821497
2
Mesna
2
Lisaftoclax
2
Injections
2
Immunotherapy, Adoptive
2
Granulocyte Colony-Stimulating Factor
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Recurrence
×
Prednisolone
×
30 days
×
Clear all
No trials found.